RCG
IBB icon

Ruggie Capital Group’s iShares Biotechnology ETF IBB Stock Holding History

Ruggie Capital Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-18,312
Closed -$1.82M – 61
2019
Q3 		$1.82M Sell
18,312
-1,864
-9% -$195K 2.41% 12
2019
Q2 		$2.2M Buy
20,176
+2,716
+16% +$289K 3.71% 7
2019
Q1 		$1.95M Sell
17,460
-4,502
-20% -$494K 2.3% 13
2018
Q4 		$2.12M Sell
21,962
-818
-4% -$86.8K 0.95% 38
2018
Q3 		$2.78M Sell
22,780
-14,709
-39% -$1.73M 1.86% 15
2018
Q2 		$4.12M Buy
37,489
+441
+1% +$47.2K 2.08% 15
2018
Q1 		$3.95M Sell
37,048
-296
-0.8% -$32.8K 2.13% 15
2017
Q4 		$3.99M Sell
37,344
-4,539
-11% -$485K 2.58% 10
2017
Q3 		$4.66M Buy
41,883
+2,475
+6% +$265K 2.99% 11
2017
Q2 		$4.07M Buy
39,408
+2,412
+7% +$238K 2.75% 11
2017
Q1 		$3.62M Buy
36,996
+13,779
+59% +$1.32M 2.69% 12
2016
Q4 		$2.06M Buy
23,217
+198
+0.9% +$18K 2.31% 13
2016
Q3 		$2.22M Buy
23,019
+2,799
+14% +$266K 1.98% 14
2016
Q2 		$1.74M Buy
20,220
+19,299
+2,095% +$1.73M 1.6% 16
2016
Q1 		$80K Buy
+921
New +$82.4K 0.08% 70
2015
Q4 		– Sell
-10,830
Closed -$1.14M – 75
2015
Q3 		$1.14M Sell
10,830
-108
-1% -$13K 1.08% 22
2015
Q2 		$1.36M Buy
10,938
+4,311
+65% +$516K 1.11% 23
2015
Q1 		$759K Sell
6,627
-5,265
-44% -$581K 0.91% 22
2014
Q4 		$2.31M Buy
+11,892
New +$1.16M 2.11% 13

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ruggie Capital Group's IBB Position: Q4 2019 in Review

Ruggie Capital Group sold out of iShares Biotechnology ETF (IBB) in Q4 2019, closing a stake of 18,312 shares — an estimated $1.82M sold.

Ruggie Capital Group first reported a position in IBB in Q4 2014 and held it in 19 quarters. The position peaked at $4.66M in Q3 2017. 710 funds tracked by Wall St. Rank hold IBB as of Q4 2019.

  • Ruggie Capital Group reported no remaining iShares Biotechnology ETF position as of Q4 2019 after selling out during the quarter.
  • Ruggie Capital Group sold 18,312 iShares Biotechnology ETF shares in Q4 2019, an estimated $1.82M.
  • Ruggie Capital Group first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 19 quarters.
  • Ruggie Capital Group's iShares Biotechnology ETF position peaked at $4.66M in Q3 2017.
  • 710 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2019.

Based on Ruggie Capital Group's 13F filing for Q4 2019, filed 14 Feb 2020.